S&P 500

5.318,04

0,21%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Dova Pharmaceuticals Inc (DOVA)
Dova Pharmaceuticals Inc (DOVA) Notícias

DOVA

Dova Pharmaceuticals (DOVA)

Dova Pharmaceuticals Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:DOVA

1 2 3 4 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
22/11/2019	18:13	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
19/11/2019	08:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
18/11/2019	08:02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
12/11/2019	18:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
12/11/2019	11:44	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:DOVA	Dova Pharmaceuticals Inc
12/11/2019	11:35	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
12/11/2019	11:33	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
12/11/2019	11:30	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
12/11/2019	11:26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
12/11/2019	11:19	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
12/11/2019	08:07	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
17/10/2019	12:23	PR Newswire (US)	Moore Kuehn, PLLC Encourages Milacron Holdings Corp. (MCRN), Ecology & Environmental, Inc. (EEI), Pivotal Software, Inc. (PVT...	NASDAQ:DOVA	Dova Pharmaceuticals Inc
11/10/2019	18:16	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
11/10/2019	18:09	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
04/10/2019	19:12	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates Dova Pharmaceuticals, Inc.	NASDAQ:DOVA	Dova Pharmaceuticals Inc
03/10/2019	17:10	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
01/10/2019	18:13	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
30/09/2019	10:57	PR Newswire (US)	Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Dova Pharmaceuticals, Inc. has obtained a Fair Price in its sal...	NASDAQ:DOVA	Dova Pharmaceuticals Inc
30/09/2019	03:00	GlobeNewswire Inc.	Dova Pharmaceuticals to be Acquired by Swedish Orphan Biovitrum AB (Sobi)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
25/09/2019	17:15	GlobeNewswire Inc.	Dova Pharmaceuticals to Present at 2019 Cantor Global Healthcare Conference	NASDAQ:DOVA	Dova Pharmaceuticals Inc
03/09/2019	17:30	GlobeNewswire Inc.	Dova Pharmaceuticals to Present at Upcoming Investor Conferences	NASDAQ:DOVA	Dova Pharmaceuticals Inc
06/08/2019	17:15	GlobeNewswire Inc.	Dova Pharmaceuticals to Present at 2019 Wedbush PacGrow Healthcare Conference	NASDAQ:DOVA	Dova Pharmaceuticals Inc
06/08/2019	08:00	GlobeNewswire Inc.	Dova Pharmaceuticals Reports Second Quarter 2019 Operating and Financial Results	NASDAQ:DOVA	Dova Pharmaceuticals Inc
30/07/2019	17:15	GlobeNewswire Inc.	Dova Pharmaceuticals to Announce Second Quarter 2019 Financial Results on August 6, 2019	NASDAQ:DOVA	Dova Pharmaceuticals Inc
19/07/2019	08:30	GlobeNewswire Inc.	Dova Pharmaceuticals Announces DOPTELET® (avatrombopag) Now Commercially Available in the United States for Treatment of Chr...	NASDAQ:DOVA	Dova Pharmaceuticals Inc
27/06/2019	09:05	GlobeNewswire Inc.	Dova Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for DOPTELET® (avatrombopag) for Treatment...	NASDAQ:DOVA	Dova Pharmaceuticals Inc
25/06/2019	09:00	GlobeNewswire Inc.	Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET® (avatrombopag) for the Treatment of Thro...	NASDAQ:DOVA	Dova Pharmaceuticals Inc
24/06/2019	09:00	GlobeNewswire Inc.	Dova Pharmaceuticals Announces Four Presentations on Avatrombopag in Patients with Chronic Immune Thrombocytopenia at the Int...	NASDAQ:DOVA	Dova Pharmaceuticals Inc
28/05/2019	17:30	GlobeNewswire Inc.	Dova Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference	NASDAQ:DOVA	Dova Pharmaceuticals Inc
23/05/2019	10:06	PR Newswire (US)	Wedbush Securities Senior Vice President of Equity Research Laura Chico, Ph.D. Initiates Coverage on Six Stocks in the Health...	NASDAQ:DOVA	Dova Pharmaceuticals Inc